Harmony Biosciences Inc.
HRMY | NASDAQ
$42.11
+$0.01 (+0.02%)
Sep 22, 2026, 1:59 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 959.9M | 899.11M | 868.45M | 825.94M | 772.53M | 744.85M | 714.73M | 681.88M | 656.11M | 617.51M | 582.02M | 541.92M | 498.86M | 471.67M | 437.86M | 400.76M | 364.29M | 331.08M | 305.44M | 270.52M | 235.39M | 199.58M |
Cost of Revenue | 235.91M | 210.86M | 198.34M | 184.21M | 167.33M | 161.33M | 156.82M | 145.56M | 135.08M | 127.94M | 121.24M | 104.97M | 95.63M | 89.55M | 83.48M | 74.41M | 66.06M | 59.82M | 55.52M | 47.62M | 40.9M | 34.67M |
Gross Profit | 723.99M | 688.25M | 670.11M | 641.74M | 605.19M | 583.53M | 557.92M | 536.32M | 521.03M | 489.57M | 460.79M | 436.95M | 403.22M | 382.12M | 354.37M | 326.35M | 298.23M | 271.26M | 249.92M | 222.9M | 194.49M | 164.9M |
Operating Income | 230.65M | 189.51M | 208.47M | 225.64M | 221.86M | 195.04M | 190.83M | 175.3M | 178.09M | 203.64M | 192.03M | 199.45M | 146.84M | 133.05M | 120.19M | 101.2M | 110.36M | 100.55M | 87.53M | 66.66M | 55.98M | 39.98M |
Interest Income | 24.41M | 22.64M | 21.92M | 20.55M | 19.75M | 19.16M | 18.54M | 18.16M | 17.34M | 16.07M | 14.73M | 10.63M | 7.47M | 4.28M | 1.27M | 1.33M | 448K | 191K | 124K | 60K | n/a | n/a |
Pretax Income | 241.2M | 197.57M | 215.06M | 230.46M | 225.14M | 197.2M | 191.8M | 175.34M | 165M | 187.4M | 173.4M | 177.81M | 133.95M | 119.08M | 104.69M | 85.06M | 66.57M | 53.43M | 37.43M | 12.75M | 25.18M | 9.06M |
Net Income | 181.27M | 145.62M | 158.69M | 185.68M | 180.9M | 152.72M | 145.49M | 122.63M | 114.99M | 137.7M | 128.85M | 150.76M | 200.24M | 189.47M | 181.47M | 155.67M | 58.11M | 48.7M | 34.6M | 11.68M | 23.2M | 9.06M |
Selling & General & Admin | 272.47M | 274.3M | 272.05M | 241.77M | 238.58M | 230.31M | 221.27M | 219.56M | 209.36M | 200.97M | 192.69M | 181.65M | 177.49M | 172.47M | 163.3M | 156.9M | 148.44M | 137.44M | 132.03M | 125.71M | 115.48M | 104.23M |
Research & Development | 220.87M | 224.44M | 189.59M | 174.33M | 144.75M | 158.18M | 145.83M | 141.47M | 133.58M | 84.96M | 76.06M | 55.85M | 78.9M | 76.6M | 70.89M | 68.25M | 39.44M | 33.27M | 30.37M | 30.54M | 23.03M | 20.7M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 493.34M | 498.73M | 461.64M | 416.1M | 383.33M | 388.49M | 367.09M | 361.03M | 342.94M | 285.93M | 268.76M | 237.5M | 256.39M | 249.07M | 234.19M | 225.14M | 187.87M | 170.7M | 162.39M | 156.24M | 138.51M | 124.92M |
Interest Expense | 13.48M | 14.05M | 14.65M | 15.31M | 16.04M | 16.8M | 17.5M | 18.08M | 20.75M | 22.56M | 23.76M | 22.54M | 20.46M | 18.43M | 16.93M | 17.6M | 18.16M | 21.2M | 24.09M | 27.81M | 29.27M | 28.98M |
Selling & Marketing Expenses | 124.54M | 120.5M | 119.51M | 117.93M | 115.96M | 114.39M | 110.92M | 110.2M | 106.04M | 102.07M | 97.4M | 91.59M | 88.64M | 84.27M | 79.29M | 77.32M | 73.33M | 70.19M | 68.12M | 66.54M | 62.66M | 58.08M |
Cost & Expenses | 729.25M | 709.59M | 659.98M | 600.31M | 550.67M | 549.81M | 523.91M | 506.58M | 478.02M | 413.87M | 389.99M | 342.47M | 352.02M | 338.62M | 317.67M | 299.56M | 253.93M | 230.53M | 217.91M | 203.86M | 179.41M | 159.6M |
Income Tax Expense | 59.93M | 51.96M | 56.38M | 44.78M | 44.24M | 44.48M | 46.31M | 52.71M | 50.01M | 49.7M | 44.54M | 27.06M | -66.29M | -70.39M | -76.78M | -70.62M | 8.46M | 4.73M | 2.83M | 1.07M | 1.97M | n/a |
Shares Outstanding (Basic) | 57.88M | 57.82M | 57.63M | 58.47M | 57.47M | 57.31M | 57.1M | 56.87M | 56.8M | 56.77M | 58.32M | 59.86M | 59.97M | 59.73M | 59.48M | 59.23M | 59.06M | 58.91M | 58.55M | 57.72M | 56.94M | 56.89M |
Shares Outstanding (Diluted) | 58.77M | 58.78M | 58.7M | 58.72M | 58.43M | 58.52M | 58.22M | 58.1M | 57.54M | 57.6M | 58.85M | 60.68M | 60.74M | 61.22M | 61.62M | 61.21M | 60.92M | 60.59M | 60.31M | 57.72M | 58.59M | 58.81M |
EPS (Basic) | 3.13 | 2.52 | 2.76 | 3.24 | 3.17 | 2.68 | 2.56 | 2.15 | 1.98 | 2.35 | 2.16 | 2.52 | 3.36 | 3.19 | 3.06 | 2.63 | 0.98 | 0.83 | 0.60 | 0.21 | 0.30 | -0.11 |
EPS (Diluted) | 3.08 | 2.48 | 2.71 | 3.18 | 3.10 | 2.62 | 2.51 | 2.11 | 1.95 | 2.31 | 2.12 | 2.46 | 3.27 | 3.10 | 2.97 | 2.56 | 0.95 | 0.80 | 0.58 | 0.20 | 0.29 | -0.11 |
EBITDA | 270.43M | 233.34M | 251.43M | 266.02M | 265.05M | 237.95M | 233.41M | 228.32M | 220.79M | 245.02M | 232.15M | 224.66M | 177.73M | 160.56M | 143.74M | 97.25M | 78.81M | 67.64M | 54.08M | 58.96M | 71.73M | 52.99M |
EBIT | 251.06M | 208M | 226.09M | 242.15M | 241.18M | 213.99M | 209.3M | 204.06M | 196.38M | 220.6M | 207.79M | 200.35M | 153.47M | 136.31M | 120.36M | 75.17M | 58.12M | 48.28M | 35.24M | 40.49M | 55.97M | 39.96M |
Depreciation & Amortization | 19.37M | 25.34M | 25.34M | 23.87M | 23.87M | 23.96M | 24.11M | 24.27M | 24.41M | 24.42M | 24.36M | 24.3M | 24.26M | 24.25M | 23.39M | 22.08M | 20.69M | 19.36M | 18.84M | 18.46M | 15.76M | 13.03M |
Add to Watchlist
Select watchlists to add or remove HRMY